What are the opening hours?

Monday 10am - 6pm Tuesday 10am - 6pm Wednesday 10am - 6pm Thursday 10am - 6pm Friday 10am - 6pm Saturday 10am - 6pm

Genes2Me

Name: Genes2Me
Address: 11th Floor, Tower B, SAS Tower, Medicity, Sector/38, Gurugram, 122001, IN
Telephone: +9118001214030

Home
India
Gurugram
Genes2Me

Genes2Me | Next Generation IVD solutions for Genomics

Genes2Me is India's leading IVD solutions manufacturer which offers NGS clinical panels, molecular POC testing solutions, RT-PCR kits, rapid antigen/antibody
testing kits, and molecular biology reagents. Additionally, Company is also a renowned genetic testing service provider with a wide range of tests targeting
infectious and non-infectious diseases, oncology, rare diseases. NGS clinical assays

from Genes2Me allow targeted testing for Oncology, Liquid Biopsy, cardiovascular conditions, neurological disorders, HLA typing, etc. With engaging innovative approaches and new ideas, the company’s flagship products Rapi-Q/ Rapi-Q HT and Rapid POC RT-PCR device are revolutionary innovations
that shall change the paradigm of molecular Point of Care testing across the world. Brands: CliSeq NGS clinical panels, PanCan, Med4Me, Exome CliSeq, CliSeq LiqBio, Rapi-Q / Rapi-Q HT, Rapi-X 16, Rapi-X 96, RapiCycler 96, RT-Direct, CoviEasy,
LeoNext

08/05/2026

This , the emphasis remains on early detection and precise viral load monitoring to enable timely clinical interventions & improved patient outcome.

's HBV-Q Real Time Kit is designed to deliver reliable HBV viral load quantification with high sensitivity & precision to support confident clinical decision making.

04/05/2026

remains a significant yet often under diagnosed public health challenge. This Hepatitis Month, reinforces the importance of early, accurate in enabling timely intervention and improved patient outcomes. Advancing precision is key to strengthening prevention strategies and safeguarding liver at scale.

01/05/2026

PanCan CGP Assay is a comprehensive, next generation sequencing-based designed for multi-cancer genomic profiling. It enables simultaneous detection of clinically relevant mutations, , MSI, fusions across wide range of solid tumors, supporting precision and personalized treatment using Cliseq Interpreter solution.

30/04/2026

is one of the most common infections worldwide - but early, accurate detection can make all the difference. Our advanced RT-PCR–based provide rapid and reliable HPV genotyping, detecting up to 28 genotypes in a single test, including high-risk strains with HPV16/18 differentiation and vaccine-target types. Empowering smarter , timely intervention, and stronger prevention.

24/04/2026

is preventable. Malaria is treatable. Yet it remains a significant public challenge.

On , let’s move beyond to action. From strengthening systems and improving access to early diagnosis, to investing in innovation and community —every step counts.

A healthier is possible when prevention reaches , everywhere.

20/04/2026

We are excited to be part of for 2026!

Join at our poster presentation to explore how precision genomics is shaping clinical decision-making in blood cancers.

📍 Poster Section: 40 | Board: 2

📅 20 April 2026

⏰ 9:00–11:00 AM

Looking forward to meaningful discussions with , clinicians, and advancing genomics.

19/04/2026

We are excited to share that we will be presenting our poster on the Advanced Panel at for Cancer Research!

📍 Poster Section 10 | Board 12

📅 April 19, 2026

⏰ 2:00–5:00 PM

Discover how our fast, point-of-care platform enables comprehensive of high-, medium-, and low-risk HPV genotypes - bringing efficiency and precision closer to where it is needed most.

Stop by to learn more, ask questions, and connect with our team! We are excited to see you there!

16/04/2026

We’re excited to be at !

Join our Innovation & Pipeline Theatre session on 18 April at 12:00 PM to explore our groundbreaking work in sepsis and diagnostics.

Find us at Booth /B12 from 18 - 21 April - see you there!

10/04/2026

On World Parkinson’s Day, let’s move the needle on early - and help bridge the care gap.

Earlier recognition means timely intervention, better outcomes, and more equitable access to the care people need. must lead to action.

07/04/2026

Together for health, standing with science to advance early .

On the occasion of , we reaffirm our commitment to strengthening through timely and accurate detection.

Early diagnostics play a critical role in improving patient outcomes, enabling informed clinical decisions, and supporting effective disease management. By advancing science-driven such as RT-PCR and molecular diagnostics, we move closer to a future where are identified earlier and treated more effectively.

Let’s continue working together towards a healthier - where innovation, accessibility, and early detection remain at the forefront of care.

04/04/2026

Many STIs are asymptomatic - and often go undetected.

Early and accurate detection plays a critical role in preventing complications and limiting transmission. RT-PCR-based diagnostics enable sensitive, specific, and rapid identification of STI pathogens, supporting clinicians with actionable insights when it matters most.

This , prioritizing early testing is a step toward better public health.

Address

11th Floor, Tower B, SAS Tower, Medicity, Sector/38
Gurugram
122001

Opening Hours

Monday	10am - 6pm
Tuesday	10am - 6pm
Wednesday	10am - 6pm
Thursday	10am - 6pm
Friday	10am - 6pm
Saturday	10am - 6pm

Telephone

+9118001214030

Website

https://www.genes2me.com/

Alerts

Be the first to know and let us send you an email when Genes2Me posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Genes2Me:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Business
Claim ownership or report listing

Want your business to be the top-listed Equipment Service in Gurugram?